ClinicalMetric / Countries / Belgium / stroke
← 🇧🇪 Belgium Trials
🇧🇪 Belgium Country × Condition

stroke Clinical Trials in Belgium

Active clinical trials for stroke with research sites in Belgium. All data sourced live from ClinicalTrials.gov — updated daily.

Active Trials: 4 // Recruiting: 4 Phases: Phase 1 // Updated: Daily
Total Trials
4
Recruiting Now
4
Country
🇧🇪 Belgium

Active Trials in Belgium (4)

NCT06612359 Phase 1
Recruiting

Impact of the BOOST GAIT Program on Gait Recovery and Functional Mobility After Stroke

Enrollment
12 pts
Country
🇧🇪 Belgium
Hasselt University
View Trial →
NCT06806761
Recruiting

Tracking Balance and Walking Recovery After Stroke

Enrollment
100 pts
Country
🇧🇪 Belgium
Vrije Universiteit Brussel
View Trial →
NCT04956185
Recruiting

Data Collection of Patients Admitted to the Stroke Unit

Enrollment
5,000 pts
Country
🇧🇪 Belgium
University Hospital, Ghent
View Trial →
NCT06767631
Recruiting

Pilot Study on Muscle, Tendon, and Neural Changes Post-Botulinum Toxin Injections in Post-stroke Spastic Equinovarus

Enrollment
12 pts
Country
🇧🇪 Belgium
Universitaire Ziekenhuizen KU Leuve...
View Trial →

Frequently Asked Questions

How many stroke clinical trials are active in Belgium?
There are currently 4 active clinical trials for stroke with sites in Belgium, of which 4 are actively recruiting patients.
How can I join a stroke clinical trial in Belgium?
To join a stroke clinical trial in Belgium, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Belgium directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are stroke trials in Belgium?
Active stroke trials in Belgium span Phase 1. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
Browse More
All Belgium Trials → Global stroke Trials → All Countries → All Trials →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology